The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BOX, RLGY, KPTI and CARB

NEW YORK, Aug. 05, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.        

Box, Inc. BOX
Class Period: November 28, 2018 to June 3, 2019
Lead Plaintiff Deadline: August 5, 2019

Throughout the class period, Box, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1)  the Company was unable to close large deals within the quarter; (2) that, as a result, the Company's revenue  would be materially impacted; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Get additional information about the BOX lawsuit: http://www.kleinstocklaw.com/pslra-1/box-inc-loss-submission-form?wire=3 

Realogy Holdings Corp. RLGY
Class Period: February 24, 2017 to May 22, 2019
Lead Plaintiff Deadline: September 9, 2019

The lawsuit alleges Realogy Holdings Corp. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Realogy was engaged in anticompetitive behavior by requiring property sellers to pay the commissions of a buyer's broker at an inflated rate; (2) Realogy's anticompetitive actions would prompt the U.S. Department of Justice ("DOJ") to open an antitrust investigation into the real estate industry's practices regarding brokers' commissions; and (3) as a result, Defendants' statements about the Realogy's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the RLGY lawsuit: http://www.kleinstocklaw.com/pslra-1/realogy-holdings-corp-loss-submission-form?wire=3 

Karyopharm Therapeutics Inc KPTI
Class Period: on behalf of shareholders of Karyopharm Therapeutics Inc. who: (1) purchased shares of Karyopharm's common stock between March 2, 2017 and February 22, 2019, inclusive; (2) purchased Karyopharm shares in or traceable to the Company's public offering of common stock conducted on or around April 28, 2017; or (3) purchased Karyopharm shares in or traceable to the Company's public offering of common stock conducted on or around May 7, 2018.
Lead Plaintiff Deadline: September 23, 2019

The lawsuit alleges that Karyopharm Therapeutics Inc made materially false and/or misleading statements and/or failed to disclose that: Throughout the Class Period, the Company continued to tout the commercial prospects for selinexor and consistently described selinexor as having a "predictable and manageable tolerability profile" and a "very nice safety profile," and assured investors that it was "well tolerated" by patients. Karyopharm also claimed that selinexor had the potential to be used as a new treatment for MM, with limited and manageable side effects. As a result of these misrepresentations, Karyopharm shares traded at artificially inflated prices during the Class Period.

Get additional information about the KPTI lawsuit: http://www.kleinstocklaw.com/pslra-1/karyopharm-therapeutics-inc-loss-submission-form?wire=3 

Carbonite, Inc. CARB
Class Period: February 7, 2019 to July 25, 2019
Lead Plaintiff Deadline: September 30, 2019

The complaint alleges Carbonite, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Carbonite's Server Backup VM Edition was of poor quality and technologically flawed; (ii) Carbonite was receiving poor reviews and complaints from customers about the Server Backup VM Edition; (iii) the poor quality and technological flaws of the Server Backup VM Edition was acting as a "disruptive" factor throughout the Carbonite salesforce and keeping that sales organization from closing opportunistically on several larger deals during fiscal 2019; and (iv) as a result of the foregoing, Carbonite lacked any reasonable for issuing its positive projections and financial forecasts.

Get additional information about the CARB lawsuit: http://www.kleinstocklaw.com/pslra-1/carbonite-inc-loss-submission-form?wire=3 

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com